首页|灯盏乙素通过调控TGF-β信号通路抑制脏器纤维化的研究进展

灯盏乙素通过调控TGF-β信号通路抑制脏器纤维化的研究进展

Research progress of inhibiting organ fibrosis by regulating TGF-β signaling pathway

扫码查看
灯盏乙素(SCU)在抑制脏器纤维化方面的研究取得了显著的进展,文章对灯盏乙素通过TGF-β信号通路在调控脏器纤维化中的作用机制进行深入探讨,并详述了灯盏乙素对肝、肺、心脏和肾等脏器纤维化的抑制效应,为揭示灯盏乙素在治疗脏器纤维化疾病中的机制提供了深刻的认识.
In recent years,significant advancements have been made in the study of Scutellarin's role in inhibiting organ fibrosis.The article delves into the mechanisms by which Scutellarin regulates organ fibrosis through the TGF-β sig-naling pathway.It provides a detailed discussion of Scutellarin's inhibitory effects on liver,lung,heart,and kidney fibrosis,offering profound insights into the mechanisms underlying Scutellarin's therapeutic potential in treating organ fibrosis diseases.

ScutellarinTGF-β signaling pathwayOrgan fibrosis

李鹏宇、夏瑜、李飞

展开 >

650500 昆明,昆明医科大学第一临床医学院

昆明医科大学

灯盏乙素 转化生长因子-β信号通路 脏器纤维化

云南省科技厅科技计划项目

202101AY070001-040

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(8)
  • 11